ACC.26: Safety and efficacy of a new drug for the treatment of uncontrolled hypertension

My name Luke Laffin and I’m a preventive cardiologist and cardiovascular clinical trialist at that Cleveland Clinic. At the ACC 2026 Scientific Sessions, I presented the results of the CARDINAL trial, which was a study of the efficacy and safety…











